PreciseDx to Collaborate with the Champalimaud Foundation to Enhance Current Approaches of Breast Cancer Risk Assessment
/PRNewswire/ -- PreciseDx, a leading AI company leveraging the analysis of morphology features from histology slides to provide more precise patient-specific...
Source: prnewswire.com